Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Outcome of Living Donor Renal Transplantation in Assiut Urology and Nephrology University Hospital ,Initial Experience

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03338140
Recruitment Status : Unknown
Verified October 2017 by Amr Mostafa Abdel Gawad, Assiut University.
Recruitment status was:  Active, not recruiting
First Posted : November 9, 2017
Last Update Posted : November 9, 2017
Sponsor:
Information provided by (Responsible Party):
Amr Mostafa Abdel Gawad, Assiut University

Brief Summary:
evaluation of outcome of living donor renal transplantation in assiut urology and nephrology university Hospital regarding the survival of patients and grafts , complications and quality of life after transplantation.

Condition or disease
Renal Transplantation

Show Show detailed description

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Assistant Lecturer of Urology in Assiut University
Actual Study Start Date : November 1, 2017
Estimated Primary Completion Date : October 1, 2019
Estimated Study Completion Date : October 1, 2019

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Evaluation of quality of life after renal transplantation [ Time Frame: 2 years ]
    Evaluation of physical and physological performance changes pre and post transplantation using kidney disease quality of life(KDQOL) score



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
-All recipients of renal transplantation in Assiut urology and nephrology university Hospital
Criteria

Inclusion Criteria:

  • All recipients of renal transplantation in Assiut urology and nephrology university Hospital

Exclusion Criteria:

  • All recipients of renal transplantation who were transplanted outside Assiut urology and nephrology university Hospital

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03338140


Locations
Layout table for location information
Egypt
Assiut university
Assiut, Egypt, 5715
Sponsors and Collaborators
Assiut University
Investigators
Layout table for investigator information
Principal Investigator: Nasreldin Abdelall, Lecturer Assiut University
Publications:

Layout table for additonal information
Responsible Party: Amr Mostafa Abdel Gawad, Assistant lecturer, Assiut University
ClinicalTrials.gov Identifier: NCT03338140    
Other Study ID Numbers: Renal transplantation
First Posted: November 9, 2017    Key Record Dates
Last Update Posted: November 9, 2017
Last Verified: October 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No